Ireland - English - HPRA (Health Products Regulatory Authority)

fort dodge animal health limited - erysipelothrix rhusiopathiae suis, strain b-7 (serotype2) inactivated - emulsion for injection - porcine - immunological - inactivated vaccine

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - erysipelothrix rhusiopathiae -

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - modified live porcine respiratory and reproductive syndrome virus - immunologicals for suidae, live viral vaccines - pigs - for active immunisation of clinically healthy pigs from 1 day of age in a porcine respiratory and reproductive syndrome (prrs) virus contaminated environment, to reduce viraemia and nasal shedding caused by infection with european strains of prrs virus (genotype 1).fattening pigs: in addition, vaccination of seronegative 1-day-old piglets was demonstrated to significantly reduce lung lesions against challenge administered at 26 weeks post vaccination. vaccination of seronegative 2-week-old piglets was demonstrated to significantly reduce lung lesions and oral shedding against challenge administered at 28 days and at 16 weeks post-vaccination.gilts and sows: in addition, pre-pregnancy vaccination of clinically healthy gilts and sows, either seropositive or seronegative, was demonstrated to reduce the transplacental infection caused by prrs virus during the third trimester of pregnancy, and to reduce the associated negative impact on reproductive performance (reduction of the occurrence of stillbirths, of piglet viraemia at birth and at weaning, of lung lesions and of viral load in lungs in piglets at weaning).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fort dodge australia pty limited - erysipelothrix rhusiopathiae-inactivated antigenic strai - immunotherapy - pigs | turkeys | boar | breeder | broiler breeder | gilt | piglet | sow | swine - erysipelas infection

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - pigs - for active immunisation of pigs from 7 weeks of age onwards to prevent mortality and reduce infection and disease caused by classical swine fever virus (csfv).onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv.onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - live attenuated aujeszky's disease virus - immunologicals - pigs - active immunisation of pigs from the age of 10 weeks to prevent the mortality and clinical signs of aujeszky's disease and to reduce the excretion of aujeszky's disease field virus. passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of aujeszky's disease and to reduce the excretion of aujeszky's disease field virus.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - inactivated viral and inactivated bacterial vaccines - pigs - for active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with pcv2.for active immunisation of pigs over the age of 3 weeks against mycoplasma hyopneumoniae to reduce lung lesions caused by infection with m. hyopneumoniae.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - porcine circovirus recombinant virus (cpcv) 1-2, inactivated - immunologicals - pigs (piglets) - active immunisation of pigs over the age of three weeks against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues, and the lesions in lymphoid tissues associated with pcv2 infection, as well as to reduce clinical signs - including loss of daily weight gain, and mortality associated with post-weaning multisystemic wasting syndrome.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - porcine circovirus vaccine (inactivated, recombinant) - immunologicals for suidae, inactivated viral vaccines - pigs (for fattening) - for active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with pcv2.,

France - English - HMA (Heads of Medicines Agencies)

pfizer gmbh - mycoplasma hyopneumoniae 1 rp - suspension for injection - pigs food - mycoplasma vaccine